Current concepts in the management of Clostridium tetani infection.
This review summarizes the microbiology, management and prevention of tetanus. Tetanus is an acute toxemic illness caused by Clostridium tetani infection at a laceration or break in the skin. It can also occur as a complication of burns, puerperal infections, umbilical stumps (tetanus neonatorum) and surgical-site infection. Tetanus is an intoxication, manifested mostly by neuromuscular dysfunction, caused by tetanal exotoxin (tetanospasmin), a potent exotoxin produced by C. tetani. It starts with tonic spasms of the skeletal muscles and is followed by paroxysmal contractions. The muscle stiffness initially involves the jaw (lockjaw) and neck and later becomes generalized. Treatment goals include interrupting the production of toxin, neutralizating the unbound toxin, controlling muscle spasms, managing dysautonomia and appropriate supportive management. Specific therapy includes intramuscular administration of tetanus immunoglobulin to neutralize circulating toxin before it binds to neuronal cell membranes. The disease can be prevented by immunization with tetanal toxoid and appropriate wound care.
Brook
Itzhak
I
Georgetown University School of Medicine, 4431 Albemarle Street NW, Washington, DC 20016, USA. ib6@georgetown.edu
D000328:Adult; D003017:Clostridium tetani / Q000378:metabolism / Q000472:pathogenicity*; D006801:Humans; D007114:Immunization; D007223:Infant; D007231:Infant, Newborn; D008666:Metalloendopeptidases / Q000276:immunology / Q000633:toxicity; D013742:Tetanus / Q000382:microbiology / Q000503:physiopathology / Q000517:prevention & control* / Q000628:therapy*; D013744:Tetanus Toxin / Q000276:immunology / Q000633:toxicity; D013745:Tetanus Toxoid / Q000008:administration & dosage
D013744:Tetanus Toxin; D013745:Tetanus Toxoid; C035979:tetanospasmin; D008666:Metalloendopeptidases